TY - JOUR
T1 - Protective effects of curcumin against lipopolysaccharide-induced toxicity
AU - Ganji, Ali
AU - Farahani, Iman
AU - Saeedifar, Amir Mohammad
AU - Mosayebi, Ghasem
AU - Ghazavi, Ali
AU - Majeed, Muhammed
AU - Jamialahmadi, Tannaz
AU - Sahebkar, Amirhossein
PY - 2021
Y1 - 2021
N2 - Background: Lipopolysaccharide (LPS), a Gram-negative bacterial cell wall component, evokes intensive inflammatory responses in the human body. Naturally, inflammation is a part of the host immune response to an infection; nonetheless, an exaggerated response can lead to a series of pathophysiological consequences, collectively known as LPS toxicity or septic shock. Objective: This review will explore the cellular and experimental investigations that mainly focus on Curcumin’s therapeutic effects on the LPS-mediated inflammatory responses. Method: A literature review of all relevant studies was performed. Conclusion: Curcumin has been reported to exert anti-inflammatory properties by interfering with LPS-induced inflammatory pathways, including binding to cell surface receptors of LPS, NF-kB activation pathway, and inflammasome activation. Further clinical studies on the effect of Curcumin in reducing the pathophysiological consequences of LPS toxicity would substantiate the use of this molecule for future therapeutic approaches.
AB - Background: Lipopolysaccharide (LPS), a Gram-negative bacterial cell wall component, evokes intensive inflammatory responses in the human body. Naturally, inflammation is a part of the host immune response to an infection; nonetheless, an exaggerated response can lead to a series of pathophysiological consequences, collectively known as LPS toxicity or septic shock. Objective: This review will explore the cellular and experimental investigations that mainly focus on Curcumin’s therapeutic effects on the LPS-mediated inflammatory responses. Method: A literature review of all relevant studies was performed. Conclusion: Curcumin has been reported to exert anti-inflammatory properties by interfering with LPS-induced inflammatory pathways, including binding to cell surface receptors of LPS, NF-kB activation pathway, and inflammasome activation. Further clinical studies on the effect of Curcumin in reducing the pathophysiological consequences of LPS toxicity would substantiate the use of this molecule for future therapeutic approaches.
KW - Curcumin
KW - Cytokine
KW - Inflammation
KW - Interleukin
KW - Lipopolysaccharide
KW - Septic shock
KW - Turmeric
UR - http://www.scopus.com/inward/record.url?scp=85118327031&partnerID=8YFLogxK
U2 - 10.2174/0929867328666210525124707
DO - 10.2174/0929867328666210525124707
M3 - Article
C2 - 34036908
AN - SCOPUS:85118327031
SN - 0929-8673
VL - 28
SP - 6915
EP - 6930
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 33
ER -